secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001654954-24-007260
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO loans Catheter Precision $500K at 8%; enters royalty agreement for LockeT device
--------------------------------------------------------------------------------

- CEO David Jenkins loaned $500,000 via 8% promissory note due August 30, 2024.
- Royalty agreement with co-inventor Auston Locke: 5% net sales of LockeT device until $1M, then 2% up to $10M; ends Dec 31, 2033 or patent expiry.
- Jenkins and affiliates hold >10% common stock, Series X preferred convertible into >8M shares, and 11.77% royalty on LockeT sales.
- Missiaen Huck, Jenkins' adult daughter, serves as non-executive COO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/0001654954-24-007260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424007260/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer